Arcutis Biotherapeutics (ARQT) logo

ARQT earnings date, and what happened the last 4 times

Next report

Wed Nov 4

Quality Score today 18

After the close, in 9 days. Confirmed by the company.

ARQT closed higher after 2 of its last 4 reports. On average it closed +4.0% the session after a report.

The moment ARQT reports

  • Its figures, in plain words
  • How it moves after, beside its last four
  • Its Quality Score going in, and after
Get an alert when ARQT reports, with its figures

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

What happened after ARQT's last 4 reports

ARQT's last 4 earnings reports
ReportedScore
going in
GapReaction
Aug 5, 20262026 · After close14estimated+7.8%-2.5%
May 6, 20262026 · After close10estimated-5.6%-14.5%
Feb 25, 20262026 · After close10estimated+2.5%+5.8%
Oct 28, 20252025 · Before open10estimated+14.6%+27.0%
  • Aug 5, 2026, after the close: the next session ARQT opened +7.8% and closed -2.5%, and five sessions on it stood -3.0%. Its Quality Score going in was 14 (Above Average), estimated.
  • May 6, 2026, after the close: the next session ARQT opened -5.6% and closed -14.5%, and five sessions on it stood -10.3%. Its Quality Score going in was 10 (Average), estimated.
  • Feb 25, 2026, after the close: the next session ARQT opened +2.5% and closed +5.8%, and five sessions on it stood -10.7%. Its Quality Score going in was 10 (Average), estimated.
  • Oct 28, 2025, before the open: that session ARQT opened +14.6% and closed +27.0%, and five sessions on it stood +26.1%. Its Quality Score going in was 10 (Average), estimated.

Across these 4 reports ARQT opened higher after 3 of 4 and closed higher after 2 of 4; on average it opened +4.8%, closed +4.0%, and stood +0.5% five sessions on. Its Quality Score is 18 today, against 14 going into its Aug 5, 2026 report.

Gap: where the stock opened the session after the report. Reaction: where that session closed. Both against the close before the report. The largest of the 4: +27.0% after the Oct 28, 2025 report. A score marked estimated was worked out afterwards from that day's prices and filings; Breakaway has recorded every score live since Sep 9 2026.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Pro members see ARQT's reaction live as a report comes out, the release's figures, and an optional alert before it reports.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Questions about ARQT's earnings

As of Oct 26, 2026: Arcutis Biotherapeutics (ARQT): reports Wed Nov 4, after the close. ARQT closed higher after 2 of its last 4 reports. Its Quality Score is 18 (Excellent). Scores as of 10:16 PM ET, 15 minutes behind.

When is ARQT's next earnings date?

Reports Wed Nov 4, after the close, a date the company confirmed. ARQT closed higher after 2 of its last 4 reports. Past behavior, not a forecast.

Does ARQT report before or after the market?

ARQT reports Wed Nov 4, after the close. Its last 4 reports came 3 after the close and 1 before the open.

How did ARQT stock react to its last earnings report?

Aug 5, 2026, after the close: the next session ARQT opened +7.8% and closed -2.5%, and five sessions on it stood -3.0%.

Does ARQT stock usually go up after earnings?

ARQT closed higher after 2 of its last 4 reports. On average it closed +4.0% the session after a report, after opening +4.8%. Past behavior, not a forecast.

Arcutis Biotherapeutics' page has its Quality Score, its chart, and its insiders' trades. Everyone reporting beside it: next week's earnings.

Past behavior, not a forecast. The score is delayed at least 15 minutes; the reports' moves are as they closed.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs; recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.